SAN FRANCISCO--(BUSINESS WIRE)--Catalia Health, a patient care management company that provides an effective, scalable, AI-powered patient engagement platform, announced today the close of its seed extension round of $2.5 million. This round, led by Khosla Ventures, will support building and deploying the company’s care management system for its first three disease states. The extension bolsters the original $1.25 million seed round led by Khosla Ventures.
Catalia Health’s patient engagement platform pairs with the company’s intelligent personalized healthcare companion, Mabu, an AI-enabled robot that combines the efficacy of conversations tailored to individual patients with the cost efficiency of scalable technology. Catalia Health combines proprietary artificial intelligence algorithms for generating conversations with the patented advantage of social robots to effectively engage patients. The patient-robot interactions make possible the collection and analysis of data critical to providing the highest level of care.
“This investment enables us to hit two major milestones: roll out Mabu to our first patients and obtain significant data that will show the benefits of our platform to patients and customers,” said Dr. Cory Kidd, CEO and founder of Catalia Health. “We’re pleased to have Khosla Ventures, one of the most prominent healthcare technology investors, back to lead our second round of funding.”
NewGen Capital and Macnica Ventures, a corporate venture capital arm of Macnica, Inc. joined Khosla Ventures in this round, as well as Q Venture Partners Limited, InnoLinks Ventures, Abstract by Flight.VC, DeNA and Lucky Capital.
“NewGen Capital is excited to join the Catalia Health team because we see great potential in utilizing artificial intelligence and natural language processing to improve patient care and monitor and increase pharmaceutical adherence,” said Homan Yuen, Managing Partner of NewGen Capital. “We firmly believe technology can be used to enhance quality of life and this is a clear example of that.”
Catalia Health will begin patient roll out in its first two disease states early summer 2017. For more information and updates, please visit www.cataliahealth.com
About Catalia Health:
Catalia Health is a San Francisco-based patient care management company founded by Cory Kidd, Ph.D in 2014. Catalia Health provides an effective and scalable patient engagement platform for individuals managing chronic disease or taking medications on an ongoing basis. The company’s AI-powered robot, Mabu enables healthcare providers and pharmaceutical companies to better support patients living with chronic illness.
Catalia Health’s care management programs are tailored to increase medication adherence, improve symptom management and reduce the likelihood that a patient is readmitted to the hospital after being discharged.
For more information, please visit www.cataliahealth.com and for a full list of investors, please visit www.cataliahealth.com/investors
